Jianchao Ge

No. 801, Heqing Road
Minhang, 200240, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction: Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype.

Correction: Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype.

Journal: Arthritis research & therapy

Published: May 27, 2026

Loss of GPR133 Promotes Enzalutamide Resistance in Prostate Cancer by Upregulating HSD3B1 and Intratumoral Androgen Synthesis.

Loss of GPR133 Promotes Enzalutamide Resistance in Prostate Cancer by Upregulating HSD3B1 and Intratumoral Androgen Synthesis.

Journal: The Prostate

Published: November 04, 2025

Single-cell RNA sequencing and proteomics uncover glycolytic dysregulation linking skin and systemic inflammation in dermatomyositis.

Single-cell RNA sequencing and proteomics uncover glycolytic dysregulation linking skin and systemic inflammation in dermatomyositis.

Journal: The British journal of dermatology

Published: August 08, 2025

Targeting USP42 induces DNA damage and inhibits cell growth in prostate cancer.

Targeting USP42 induces DNA damage and inhibits cell growth in prostate cancer.

Journal: Frontiers in molecular biosciences

Published: June 13, 2025

Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression.

Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression.

Journal: Journal of cancer research and clinical oncology

Published: February 08, 2025

Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype.

Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype.

Journal: Arthritis research & therapy

Published: September 15, 2024

Androgen receptor deficiency-induced TUG1 in suppressing ferroptosis to promote benign prostatic hyperplasia through the miR-188-3p/GPX4 signal pathway.

Androgen receptor deficiency-induced TUG1 in suppressing ferroptosis to promote benign prostatic hyperplasia through the miR-188-3p/GPX4 signal pathway.

Journal: Redox biology

Published: April 12, 2024

Arctigenin inhibits high glucose-induced EMT and cell proliferation to alleviate benign prostatic hyperplasia companied with type 2 diabetes mellitus through MBOAT4/ acylated Ghrelin/GHS-R.

Arctigenin inhibits high glucose-induced EMT and cell proliferation to alleviate benign prostatic hyperplasia companied with type 2 diabetes mellitus through MBOAT4/ acylated Ghrelin/GHS-R.

Journal: Chemico-biological interactions

Published: April 10, 2024

Endogenous Zinc-Ion-Triggered In Situ Gelation Enables Zn Capture to Reprogram Benign Hyperplastic Prostate Microenvironment and Shrink Prostate.

Endogenous Zinc-Ion-Triggered In Situ Gelation Enables Zn Capture to Reprogram Benign Hyperplastic Prostate Microenvironment and Shrink Prostate.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: August 03, 2023

Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer.

Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer.

Journal: Frontiers in genetics

Published: November 29, 2022

Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling.

Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling.

Journal: Journal of oncology

Published: June 11, 2021

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc.

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 18, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026